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Diabetes mellitus in Addis Ababa, Ethiopia: admissions,  
complications and outcomes in a large referral hospital
M. Gizaw,1 A. D. Harries,2,3 S. Ade,2,4 K. Tayler-Smith,5 E. Ali,5 N. Firdu,1 H. Yifter6
Chronic non-communicable diseases have emerged as the next twenty-first century global epidemic 
and have already become the leading causes of death 
and disability worldwide.1 Among these, the global 
burden of diabetes mellitus (DM) is immense. In 2013, 
an estimated 382 million people were living globally 
with DM, with numbers expected to rise to 592 mil-
lion by 2030.2 Most of these persons have type 2 DM, 
and given the association between DM and unhealthy 
lifestyles, such as poor diet and physical inactivity, 
there are more people with DM in urban than in rural 
areas; this divide is estimated to reach 314 million and 
143 million, respectively, in 2030. In 2013, DM-re-
lated complications were a major cause of disability 
and reduced quality of life, and an estimated 5 million 
people aged 20–79 years worldwide died prematurely 
from the disease.2
Although Asia is the epicentre of the DM pan-
demic, there is an increasing burden of disease in 
sub-Saharan African countries.3 A systematic review of 
studies in Ethiopia from 1970 to 2011 suggested that 
DM prevalence in the country was about 2%, rising to 
5% in persons aged 40 years in certain settings.4 A 
more recent nationwide World Health Organization 
(WHO) STEPS survey among 2153 persons in Ethiopia 
found the DM prevalence to be 6.5%.5 It is therefore 
important to monitor and anticipate the growing bur-
den of DM and related complications, together with 
treatment outcomes, for the purpose of resource plan-
ning (i.e., the human and material resources needed 
to diagnose, treat and manage this disease) and to in-
form future control and management strategies.
A previous study in two specialised hospitals in Ad-
dis Ababa documented the trend in DM admissions be-
tween 2005 and 2009, noting that admissions increased 
from 51 per annum to 245 over this period.6 Up-to-date 
information on the indications for hospital admission, 
the types of DM, existing complications and hospital 
outcomes is important, as this will help policy makers 
and health care staff better understand the DM burden 
and associated comorbidities. In Ethiopia, where there 
are no community-level studies on the burden of DM, 
hospital data serve as a useful proxy.
The aim of the present study was therefore to docu-
ment indications for admission, complications and 
hospital outcomes of patients with DM admitted to 
the largest referral hospital (in Addis Ababa, Ethiopia), 
and compare findings between patients with type 1 
and type 2 DM. Specific objectives for patients strati-
fied by type of DM were to describe 1) demographic 
characteristics and indications for hospital admission, 
2) existing complications and comorbidities, and 3) 
hospital outcomes.
METHODS
Study design
This was a retrospective descriptive study using medi-
cal files.
Setting
General setting
Ethiopia, located in the Horn of Africa, is the third 
most populated country in sub-Saharan Africa, with 
80 million inhabitants, of whom 80% live in rural 
areas. The country has around 80 different ethnic 
groups. Addis Ababa is the capital city of Ethiopia, 
with a population of over 3 million, according to the 
2007 population census, and an annual estimated 
growth rate of 3.8%.7 The country is poor, with a gross 
national income per capita of US$1110 in 2012.8 In-
fectious and communicable diseases account for about 
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Setting: The Black Lion Referral Hospital, Addis Ababa, 
Ethiopia.
Objective: To document indications for admission, com-
plications and outcomes of patients with diabetes melli-
tus (DM) admitted between 2010 and 2013.
Design: A descriptive retrospective study using medical 
files.
Results: Of 8048 admissions, 523 (6.5%) had DM; of 
these, 418 medical records were retrieved: 301 (72%) 
patients had type 2 and 104 (28%) type 1 disease, with 
male sex (62%) and older age (median age 60 years) be-
ing features of type 2 disease. Main admission diagnoses 
for type 2 disease were diabetic foot ulcer (39%) and car-
diovascular disease (21%); for type 1 disease, it was dia-
betic ketoacidosis (62%). Hypertension, neuropathy, ne-
phropathy, retinopathy and diabetic foot accounted for 
85% of the 756 existing complications. Overall in-patient 
mortality was 21%. Of the 89 deaths, 77 occurred 
among patients with type 2 disease; the main indications 
for admission were diabetic foot ulcer/gangrene and car-
diovascular disease.
Conclusion: DM, especially type 2 DM, is an important 
cause of admission to Ethiopia’s largest referral hospital. 
Many patients had already developed disease-related 
complications at admission, and mortality was high. 
There is a need to improve awareness about and care for 
DM in Ethiopia.
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60–80% of the health problems in the country, al-
though non-communicable diseases are thought to be 
rapidly increasing.9
Study site
The Black Lion Hospital (Tikur Anbessa in Amharic) is 
Ethiopia’s largest specialised and referral public hospi-
tal. In 1998, the hospital was handed over to Addis 
Ababa University by the Ministry of Health so that it 
could also function as a teaching hospital. The hospi-
tal has more than 800 beds and offers diagnosis and 
treatment for approximately 400 000 in-patients and 
out-patients a year. The hospital receives patients who 
are referred from across the country, as well as spa-
tients from Addis Ababa.
DM management
Patients with DM are mainly classified as type 1 and 
type 2, with specific forms of DM and gestational dia-
betes making up the remainder. Type 1 DM is managed 
with insulin, while type 2 is managed by lifestyle and 
dietary advice, oral medications (mainly sulphony-
lureas and metformin) and short-, medium- and 
long-acting insulin. Patients are usually managed on 
an out-patient basis in a specialised diabetes clinic, but 
are admitted if they develop acute (hypoglycaemia or 
ketoacidosis) or more chronic complications (cardio-
vascular disease, stroke, foot disease).
Patient population
All patients with DM (previously known or diagnosed 
on the current admission) who were admitted to the 
wards of the Department of Internal Medicine at the 
Black Lion Hospital, between January 2010 and De-
cember 2013 were included in the study.
Data variables, data collection and sources of data
Data variables collected in relation to the study objec-
tives included the number of medical admissions each 
year and the number with a hospital in-patient admis-
sion diagnosis of DM collected from the hospital 
health information system logbooks; age; sex; resi-
dence; type of DM; indications for hospital admission; 
existing complications and hospital discharge out-
comes collected from patient medical charts. A data 
abstraction sheet was prepared into which the relevant 
data were entered. The data were collected in August 
2014 by identifying the medical record number from 
the Health Management Information System log book, 
which was then used to trace and access individual pa-
tient medical charts. The principal investigator led the 
abstraction process, aided by local co-investigators.
Analysis and statistics
Data were single-entered from the paper-based abstrac-
tion sheet into an electronic EpiData file (version 3.1, 
EpiData Association, Odense, Denmark). A descriptive 
analysis with frequencies and proportions was carried 
out. Baseline characteristics and hospital outcomes were 
compared between patients with type 1 and type 2 DM 
using the χ2 test, with levels of significance set at 5%.
Ethics
Permission for the study was obtained from the Re-
search and Ethics Committee of the School of Public 
Health and the Department of Internal Medicine, 
School of Medicine, Addis Ababa University. The study 
met the Médecins Sans Frontières (MSF) Ethics Review 
Board (Geneva, Switzerland) approved criteria for stud-
ies of routinely collected data, and was approved by 
the Ethics Advisory Group of the International Union 
Against Tuberculosis and Lung Disease, Paris, France. 
Names were not used in collecting the data from the 
medical files, and confidentiality was maintained by 
keeping the data collection forms locked in a secure 
cabinet; the electronic data file was kept securely in a 
password protected computer.
RESULTS
Between 2010 and 2013, there were 8048 hospital ad-
missions to the Department of Internal Medicine, of 
which 523 (6.5%) were recorded as DM. The numbers 
and proportions of patients admitted with DM each 
year are as follows: 138 (8%) in 2010, 118 (7%) in 
2011, 159 (7%) in 2012 and 108 (4%) in 2013.
Of the 523 logbook entries, 418 medical records 
were retrieved: 50 records were from patients who did 
not in fact have DM, and 55 records could not be 
found. Of the patients with medical records, 306 (73%) 
lived in Addis Ababa; the remainder had been referred. 
Demographic characteristics and indications for hospi-
tal admission for all patients and for those with type 1 
and type 2 DM are shown in Table 1. Type 2 DM ac-
counted for nearly three quarters of all admissions; 
this group had a higher proportion of males and a 
higher median age (60 years) than the group with type 
1 DM. Nearly one third of the patients were admitted 
with diabetic foot ulcer/gangrene, about 20% with dia-
betic ketoacidosis or cardiovascular disease/stroke and 
nearly 10% with renal failure. Infections were respon-
sible for 13% of admissions, with active tuberculosis 
(TB) accounting for 5% of these. In those with type 2 
DM there was a significantly higher burden of diabetic 
foot ulcer, congestive cardiac failure, myocardial in-
farction and stroke, and a significantly lower frequency 
of diabetic ketoacidiosis compared with the group 
with type 1 DM.
A large number of patients had existing complica-
tions (Table 2). Hypertension, chronic complications 
of DM such as neuropathy, nephropathy and retinopa-
thy, and previous diabetic foot infections accounted 
for 85% of these. The only significant difference be-
tween patients with type 1 and those with type 2 DM 
was that the existing complication of ischaemic heart 
disease and/or previous myocardial infarction was 
only observed in those with type 2 DM.
The median period of hospitalisation for all pa-
tients was 12 days (interquartile range [IQR] 6–23); for 
those with type 1 DM it was 8 days (IQR 5–16) and for 
type 2 DM it was 14 days (IQR 7–25). Hospital out-
comes for all patients and for those with type 1 DM 
and type 2 DM are shown in Table 3. The in-hospital 
mortality rate among all DM patients was high (21%), 
and 26% more common for type 2 DM patients than 
in those with type 1 DM. In patients who died, the in-
dications for hospital admission in relation to type of 
ACKNOWLEDGEMENTS
This research was conducted 
through the Structured 
Operational Research and 
Training Initiative (SORT IT), 
a global partnership led by 
the Special Programme for 
Research and Training in 
Tropical Diseases at the 
World Health Organization 
(WHO/TDR, Geneva, 
Switzerland). The model is 
based on a course developed 
jointly by the International 
Union Against Tuberculosis 
and Lung Disease (The 
Union, Paris, France) and 
Medécins Sans Frontières 
(MSF, Brussels Operational 
Centre, Luxembourg). The 
specific SORT IT programme 
which resulted in this 
publication was jointly 
developed and implemented 
by: the Operational Research 
Unit (LUXOR), MSF Brussels 
Operational Center; the 
Centre for Operational 
Research, The Union; the 
Centre for International 
health, University of Bergen, 
Bergen, Norway; the 
Institute of Tropical 
Medicine, Antwerp, Belgium; 
The University of Nairobi, 
Nairobi, Kenya and the 
University of Chester, 
Chester, United Kingdom.
The programme was funded 
by The Union, MSF, the 
Department for International 
Development (DFID, 
London, UK) and WHO. We 
also thank the School of 
Public Health, Addis Ababa 
University, Addis Ababa, 
Ethiopia, for financial 
support. The funders had no 
role in study design, data 
collection and analysis, 
decision to publish or 
preparation of the 
manuscript. 
In accordance with WHO’s 
open-access publication 
policy for all work funded by 
WHO or authored/
co-authored by WHO staff 
members, the WHO retains 
the copyright of this 
publication through a 
Creative Commons 
Attribution 
intergovernmental 
organisation licence (http://
creativecommons.org/
licenses/by/3.0/igo/
legalcode) which permits 
unrestricted use, distribution 
and reproduction in any 
medium provided the 
original work is properly 
cited.
Conflict of interest: none 
declared.
Public Health Action DM in Addis Ababa, Ethiopia  76
DM are shown in Table 4. Although there were no significant dif-
ferences due to the small numbers, diabetic foot ulcer/gangrene, 
cardiovascular disease, stroke and renal disease were the most 
common reasons for admission among those with type 2 DM. A 
significant difference in mortality was found in those with dia-
betic ketoacidosis due to type 1 DM compared to type 2 DM.
DISCUSSION
This study shows that patients with DM constituted 5% of all 
medical admissions to the largest referral hospital in Ethiopia, 
with the disease burden remaining roughly the same between 
2010 and 2013. The majority had type 2 DM; patients were gener-
ally male, with a median age of 60 years. In this group, diabetic 
foot ulcer and non-communicable disease constituted the most 
common reasons for hospital admission. About one quarter of the 
patients with type 1 DM were young, and ketoacidosis was the 
most common cause of admission in this group. The proportion 
of patients admitted with type 1 DM was higher than normally 
observed in other African settings; this may be related to malnu-
trition-related disease, which is known to be common in Ethio-
pia.10 The prevalence of infection and active TB was similar for 
both types of DM, with TB being the cause of hospital admission 
in one in 20 patients. Recent systematic reviews have found that 
DM patients are two to three times more likely to develop TB 
than others,11,12 and the last few years have seen a global increase 
in this dual disease burden.13
The majority of patients admitted with DM already had exist-
ing complications and comorbidities requiring ongoing care both 
in hospital and in the community once the patent has been dis-
charged. The existing complications, added to the indications for 
hospital admission, were probably responsible for the high 
in-hospital mortality observed overall, and particularly those with 
type 2 DM, in whom diabetic foot ulcer and cardiovascular dis-
ease were the main admission indications that eventually lead to 
death.
The strengths of this study were that it included all DM pa-
tients admitted to this large referral hospital during a 4-year pe-
TABLE 1 Demographic characteristics and indications for hospital admission in patients with DM admitted to the Black 
Lion Hospital, Addis Ababa, Ethiopia, 2010–2013
Characteristics
All patients with DM*
n (%)
DM type 1
n (%)
DM type 2
n (%) P value
All patients 418 104 301
Demographic characteristics:
 Male 243 (58) 50 (48) 186 (62) 0.01
 Female 175 (42) 54 (52) 115 (38) 0.01
 Age, years, median [IQR] 55 [38–65] 25 [19–30] 60 [50–69] 0.001
Indications for hospital admission
 Diabetic foot ulcer or gangrene 130 (31) 7 (7) 119 (39) 0.001
 Diabetic ketoacidosis 87 (21) 65 (62) 16 (5) 0.001
 Congestive cardiac failure 43 (10) 3 (3) 39 (13) 0.006
 Myocardial infarction 25 (6) 2 (2) 23 (8) 0.03
 Renal failure (acute or acute on chronic) 39 (9) 9 (9) 30 (10) 0.70
 Stroke 15 (4) 0 14 (5) 0.02
 Active tuberculosis 19 (5) 5 (5) 14 (5) 0.90
 Other infections 34 (8) 9 (9) 24 (8) 0.80
 Other (electrolyte imbalance, anaemia, malignancy) 19 (4) 3 (3) 16 (5) 0.46
 Hypoglycaemia 7 (2) 1 (1) 6 (2) 0.68
* Of 418 patients with medical records, 13 had no data on type of DM.
DM = diabetes mellitus; IQR = interquartile range.
TABLE 2 Existing complications and comorbidities in patients with diabetes admitted to the Black Lion Hospital, Addis 
Ababa, Ethiopia, stratified by type 1 and type 2 DM, 2010–2013
Existing complications and comorbidities
All patients with DM*
n (%)
DM type 1
n (%)
DM type 2
n (%) P value
All complications† 756 80 651
Hypertension 208 (28) 23 (29) 177 (27) 0.77
Ischaemic heart disease or previous myocardial infarction 63 (8)  0 63 (10) 0.001
Stroke 28 (4) 2 (3) 23 (4) 0.63
Diabetic foot infection 124 (16) 9 (11) 111 (17) 0.21
Below knee amputation 23 (3)  0 21 (3) 0.20
Diabetic nephropathy 119 (16) 17 (21) 100 (15) 0.23
Diabetic neuropathy 109 (14) 16 (20) 89 (14) 0.13
Diabetic retinopathy 82 (11) 13 (16) 67 (10) 0.11
* Of existing complications in patients with medical records, 25 had no recorded data on type of DM.
† Some patients had two or more existing complications
DM = diabetes mellitus.
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riod, and there was no need for any sampling framework. The 
study report also followed the Strengthening the Reporting of Ob-
servational Studies in Epidemiology (STROBE) guidelines.14 Lim-
itations included the operational nature of the study and the use 
of data already collected from patient files, which might have 
been inaccurate. Moreover, in nearly 10% of the patients regis-
tered as having DM in the health information log books, this in-
formation was incorrect, and in another 10% the patients’ medi-
cal charts could not be found.
The findings of this study support the belief that DM is a large 
and growing global public health problem, especially in low- and 
middle-income countries and in sub-Saharan Africa.2,15 The main 
indication for admission was diabetic foot ulcer/gangrene, espe-
cially in patients with type 2 DM, in line with other reports in Af-
rica.16 Although we have no evidence, this may be related to poor 
glycaemic control prior to hospital admission, which in turn may 
be related to difficult access to medication or poor adherence to 
medication guidance, as has been observed elsewhere in Ethio-
pia.17 The proportion of patients who died in this study was 
higher than reported previously.6 However, high rates of hospital 
mortality have been associated elsewhere with diabetic foot ulcer 
and cardiovascular disease,18,19 and these were the most common 
indications for hospital admission in the present study. Associ-
ated hypertension is also known to increase the risk of cardiovas-
cular disease and mortality.18
There are several implications of our study. First, better 
awareness about and community mobilisation for the preven-
tion and care of DM is needed in the community and among 
health care staff, and this includes health decision makers who 
need to consider capacity development and appropriate re-
sources. This in turn can be supported by early screening of peo-
ple attending health facilities, including those over a certain 
age, such as 40–50 years, those at risk of non-communicable dis-
eases and pregnant women, as in other countries.20 Second, dis-
cussion and advocacy for free medication is needed for those liv-
ing in low- and middle-income countries to support what is in 
effect life-long treatment. Third, special attention should be 
given to those who are admitted with diabetic foot ulcer or car-
diovascular complications, as these are leading causes of death; 
good blood pressure control should also be emphasised. The 
high rates of in-hospital mortality need to be reduced, and ear-
lier detection and better case management of those at risk of 
death may contribute to this reduction. Fourth, as DM patients 
are two to three times more likely to develop TB than other pa-
tients,11,12 consideration should be given to routine screening of 
DM admissions for symptoms and signs of TB. Evidence suggests 
that it is worthwhile screening persons with DM for TB in coun-
tries such as Ethiopia, where TB case notification rates exceed 
100 per 100 000 population. This approach has also been en-
dorsed by WHO and the International Union Against Tuberculo-
sis and Lung Disease.21,22 Finally, the hospital needs to improve 
on its health information systems and storage of medical 
records.
In conclusion, DM constituted an important cause of admis-
sion to the medical wards of the largest referral hospital in Ethio-
pia. Type 2 DM predominated, with diabetic foot ulcer and associ-
ated non-communicable diseases being important causes of 
existing comorbidity and admission. These in turn were associ-
ated with high in-patient mortality. There is a need to improve 
awareness and care in the management of DM in Ethiopia.
TABLE 3 Hospital outcomes among patients with diabetes admitted to the Black Lion Hospital, 
Addis Ababa, Ethiopia, stratified by type 1 and type 2 DM, 2010–2013
Hospital outcome
All patients with DM*
n (%)
DM type 1
n (%)
DM type 2
n (%) P value
All admissions 418 104 301
Discharged from hospital 301 (72) 87 (84) 204 (68) 0.002
Died in hospital 89 (21) 10 (9) 77 (25) 0.001
Absconded 14 (3.5) 2 (2) 11 (4) 0.59
Not recorded 14 (3.5) 5 (5) 9 (3) 0.57
* Of 418 patients with medical records, 13 had no recorded data on type of DM.
DM = diabetes mellitus.
TABLE 4 Indications for admission in patients with type 1 and type 2 DM who died in the Black Lion Hospital, Addis 
Ababa, Ethiopia, 2010–2013
Indications for hospital admission
DM type 1 patients who died
n (%)
DM type 2 patients who died
n (%) P value
All deaths 10 77
Diabetic foot ulcer or gangrene 1 (10) 21 (27) 0.43
Diabetic ketoacidosis 3 (30) 1 (1) 0.01
Congestive cardiac failure 0 14 (18) 0.31
Myocardial infarction 2 (20) 6 (8) 0.49
Renal failure (acute or acute or chronic) 3 (30) 9 (12) 0.12
Stroke 0 6 (8) 0.80
Active tuberculosis 0 7 (9) 0.70
Other infections 1 (10) 7 (9) 0.63
Other (electrolyte imbalance, anaemia, malignancy) 0 5 (6) 0.91
Hypoglycaemia 0 1 (2) 0.22
DM = diabetes mellitus.
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Contexte  :  Hôpital de référence du Black Lion, Addis Ababa, Ethiopie.
Objectif  :  Documenter les indications d’admission, les complications 
et le devenir des patients atteints de diabète (DM) admis à l’hôpital 
entre 2010 et 2013.
Schéma  :  Etude descriptive rétrospective sur dossiers médicaux.
Résultats  :  Sur 8048 admissions, 523 (6,5%) avaient un DM et parmi 
eux, 418 dossiers médicaux ont été retrouvés : 301 (72%) patients 
avaient un DM de type 2 et 104 (28%) avaient un DM de type 1 ; les 
hommes (62%) et les personnes âgées (âge médian 60 ans) étaient 
caractéristiques du type 2. Les diagnostics d’admission les plus 
fréquents du type 2 étaient l’ulcère diabétique du pied (39%) et les 
problèmes cardiovasculaires (21%), et celui du type 1, l’acidocétose 
diabétique (62%). L’hypertension, les neuropathies, les 
néphropathies, la rétinopathie et le pied diabétique représentaient 
85% des 756 complications existantes. La mortalité totale des 
patients admis a été de 21%. Sur ces 89 décès, 77 patients étaient de 
type 2 avec comme indications principales d’admission l’ulcère 
diabétique du pied/la gangrène et les problèmes cardiovasculaires.
Conclusion  :  Le DM, surtout de type 2, est une cause importante 
d’admission dans le plus grand hôpital de référence du pays. De 
nombreux patients avaient déjà développé des complications liées 
au DM lors de l’admission, et la mortalité a été élevée. Il est 
nécessaire d’améliorer la connaissance et les soins relatifs au DM en 
Ethiopie.
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Marco de referencia: El hospital de referencia Black Lion de Addis 
Abeba en Etiopía.
Objetivo: Documentar las indicaciones de hospitalización, las 
complicaciones y los desenlaces clínicos de los pacientes con diabetes 
(DM) hospitalizados entre el 2010 y el 2013.
Métodos: Fue este un estudio descriptivo retrospectivo realizado a 
partir de las historias clínicas.
Resultados: En las 8048 hospitalizaciones hubo 523 casos de DM 
(6,5%); se consultaron 418 historias clínicas. En 301 pacientes el 
diagnóstico fue DM de tipo 2 (72%) y en 104 casos fue DM de tipo 1 
(28%); los pacientes con DM de tipo 2 eran predominantemente de 
sexo masculino (62%) y de edad avanzada (mediana de la edad 60 
años). El principal motivo de hospitalización en el grupo de DM de 
tipo 2 fue la úlcera diabética del pie (39%) y la enfermedad 
cardiovascular (21%) y en el grupo con DM de tipo 1 fue el estado 
de cetoacidosis (62%). De las 756 complicaciones existentes, el 85% 
consistieron en hipertensión neuropatía, retinopatía y pie diabético. 
La mortalidad intrahospitalaria global fue 21%; de las 89 defunciones, 
77 correspondieron a pacientes con DM de tipo 2, hospitalizados por 
pie diabético o gangrena y enfermedad cardiovascular.
Conclusión: La DM de tipo 2 representa una causa importante de 
hospitalización en el principal hospital de referencia del país. Muchos 
pacientes presentaban complicaciones relacionadas con la 
enfermedad en el momento de la hospitalización y la mortalidad fue 
alta. Es necesario consolidar la sensibilización con respecto a la DM y 
a la atención de estos pacientes en Etiopía.
